Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives
- PMID: 3886401
- DOI: 10.1007/BF00635700
Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives
Abstract
The effect on arterial pressure of incremental doses of norepinephrine (2 to 10 micrograms/min) and angiotensin II (50 to 800 ng/min) administered over 10 min periods was studied in sodium-replete hypertensive patients after crossover oral treatments with placebo, captopril 50 mg in a single dose, captopril 50 mg three times daily for one week and hydrochlorothiazide 50 mg daily for a week. Neither captopril nor hydrochlorothiazide affected the dose response to infusions of angiotensin II. In comparison to placebo responses, however, both single and multiple-dose captopril therapy, and hydrochlorothiazide attenuated the pressor responses to infusions of norepinephrine. Captopril significantly depressed angiotensin converting enzyme activity from pre-dose levels and angiotensin II infusions significantly elevated plasma aldosterone concentrations. These results confirm findings reported for single dose captopril in normotensive volunteers and indicate that attenuation of the vascular responsiveness to sympathetic stimulation may contribute to the antihypertensive effects of captopril and hydrochlorothiazide therapy.
Similar articles
-
[Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].Arch Inst Cardiol Mex. 1982 Jul-Aug;52(4):295-300. Arch Inst Cardiol Mex. 1982. PMID: 6291470 Spanish.
-
Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.Clin Sci (Lond). 1979 Dec;57 Suppl 5:135s-138s. doi: 10.1042/cs057135s. Clin Sci (Lond). 1979. PMID: 232017 Clinical Trial.
-
Captopril attenuates pressor responses to norepinephrine and vasopressin through depletion of endogenous angiotensin II.Am J Cardiol. 1982 Apr 21;49(6):1537-9. doi: 10.1016/0002-9149(82)90381-2. Am J Cardiol. 1982. PMID: 7041592
-
Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension.Clin Sci (Lond). 1984 Mar;66(3):299-305. doi: 10.1042/cs0660299. Clin Sci (Lond). 1984. PMID: 6362960
-
Effects of captopril in animal models of hypertension.Clin Exp Hypertens (1978). 1980;2(3-4):613-37. doi: 10.3109/10641968009037133. Clin Exp Hypertens (1978). 1980. PMID: 7000464 Review. No abstract available.
Cited by
-
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003. Drugs. 1988. PMID: 3063499 Review.
-
A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.Eur J Clin Pharmacol. 1990;38(4):351-7. doi: 10.1007/BF00315574. Eur J Clin Pharmacol. 1990. PMID: 2188845 Clinical Trial.
-
Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.Clin Pharmacokinet. 1988 Apr;14(4):241-59. doi: 10.2165/00003088-198814040-00002. Clin Pharmacokinet. 1988. PMID: 3292102 Review.
-
The effect of acute and chronic captopril therapy on baroreflex function in man.Br J Clin Pharmacol. 1988 Mar;25(3):315-21. doi: 10.1111/j.1365-2125.1988.tb03309.x. Br J Clin Pharmacol. 1988. PMID: 3129008 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical